Intellia Therapeutics (NTLA)
(Delayed Data from NSDQ)
$27.51 USD
+0.49 (1.81%)
Updated Mar 28, 2024 03:59 PM ET
After-Market: $28.00 +0.49 (1.78%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/02/2024
Time: -- |
3/2024 | $-1.34 | -4.48% |
Earnings Summary
For their last quarter, Intellia Therapeutics (NTLA) reported earnings of -$1.46 per share, beating the Zacks Consensus Estimate of $-1.47 per share. This reflects a positive earnings surprise of 0.68%. Look out for NTLA's next earnings release expected on May 02, 2024. For the next earning release, we expect the company to report earnings of -$1.34 per share, reflecting a year-over-year decrease of 14.53%.
Earnings History
Price & Consensus
Zacks News for NTLA
Intellia Therapeutics, Inc. (NTLA) Crossed Above the 50-Day Moving Average: What That Means for Investors
NTLA: What are Zacks experts saying now?
Zacks Private Portfolio Services